Further analysis showed that HSPA1A, HSPA1B, HSPA4, HSPA5, HSPA8, HSPA13, and HSPA14 could be used as prognosis biomarkers, and HSPA4 HSPA14 as independent risk factors to determine the prognosis of HCC patients. Here, HSPA8 is linked to hepatocellular carcinoma.